Skip to main content

Alejandra Gabaldon Dominguez

Institutions of which they are part

Research technician
Translational Molecular Pathology
Vall Hebron Institut de Recerca
Alejandra Gabaldon Dominguez

Alejandra Gabaldon Dominguez

Alejandra Gabaldon Dominguez

Institutions of which they are part

Research technician
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Marcadores pronósticos en nefritis lúpica, implicación del complemento

IP: Maria Jose Soler Romeo
Collaborators: Alejandra Gabaldon Dominguez, Marc Patricio Liebana, Sheila Bermejo Garcia
Funding agency: Sociedad Española de Nefrología (S.E.N.)
Funding: 24000
Reference: SENEFRO/AYUDAS.INVEST/2025/SOLER
Duration: 01/12/2025 - 30/11/2027

Hacia un manejo clínico personalizado de pacientes oncológicos con fracaso renal agudo asociado a los immune-checkpoint inhibitors (ICIs)

IP: Maria Jose Soler Romeo
Collaborators: Alejandra Gabaldon Dominguez, Sara Nuñez Delgado, Oriol Bestard Matamoros, Sheila Bermejo Garcia, Concepció Jacobs Cachá, Elena Isabel Crespo Gimeno
Funding agency: Instituto de Salud Carlos III
Funding: 246840
Reference: AC22_00029
Duration: 01/01/2023 - 30/06/2026

Desentrañando las vías protectoras de los SGLT2i y GLP-1RA en la enfermedad renal diabética: papel de las proteínas adaptadoras MAP17 y D-AKAP-2 en ratones db/db y organoides renales humanos.

IP: Maria Jose Soler Romeo
Collaborators: Alejandra Gabaldon Dominguez, Mario Alonso Narvaez Barros, Pamela Dominguez Baez, Irene Martinez Diaz, Sheila Bermejo Garcia, Alejandra Planas Vilaseca, Concepció Jacobs Cachá
Funding agency: Instituto de Salud Carlos III
Funding: 122210
Reference: PI21/01292
Duration: 01/01/2022 - 30/06/2026

Inmunomonitorización personalizada para estratificar los pacientes con lupus eritematoso sistémico

IP: Josefina Cortes Hernandez
Collaborators: Alejandra Gabaldon Dominguez, Teresa Moline Marimon, Sheila Bermejo Garcia
Funding agency: Instituto de Salud Carlos III
Funding: 141570
Reference: PI21/00287
Duration: 01/01/2022 - 31/12/2024

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Sara Garcia Ortega

Sara Garcia Ortega

Predoctoral researcher
Translational Molecular Pathology
Read more
Alba González Robles

Alba González Robles

Predoctoral researcher
Infectious Diseases
Read more
Maria Martinez Pla

Maria Martinez Pla

Main researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Anna Gros Turpin

Anna Gros Turpin

Main researcher
Multidisciplinary Nursing Research Group
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.